MY6300044A - Resin drug compounds - Google Patents

Resin drug compounds

Info

Publication number
MY6300044A
MY6300044A MY196344A MY6300044A MY6300044A MY 6300044 A MY6300044 A MY 6300044A MY 196344 A MY196344 A MY 196344A MY 6300044 A MY6300044 A MY 6300044A MY 6300044 A MY6300044 A MY 6300044A
Authority
MY
Malaysia
Prior art keywords
drug compounds
resin drug
resin
compounds
drug
Prior art date
Application number
MY196344A
Inventor
Herbert Linnell Wilfred
Paul Rety Stephen
Original Assignee
Clinical Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Products Ltd filed Critical Clinical Products Ltd
Publication of MY6300044A publication Critical patent/MY6300044A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY196344A 1957-03-14 1963-12-31 Resin drug compounds MY6300044A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8431/57A GB857193A (en) 1957-03-14 1957-03-14 Resin-drug compounds

Publications (1)

Publication Number Publication Date
MY6300044A true MY6300044A (en) 1963-12-31

Family

ID=9852368

Family Applications (1)

Application Number Title Priority Date Filing Date
MY196344A MY6300044A (en) 1957-03-14 1963-12-31 Resin drug compounds

Country Status (2)

Country Link
GB (1) GB857193A (en)
MY (1) MY6300044A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242049A (en) * 1963-05-20 1966-03-22 Ncr Co Process for making enterically useful complex of spiramycin and product thereof
DE2929456A1 (en) * 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CH655507B (en) * 1983-01-12 1986-04-30
FR2576213B1 (en) * 1985-01-21 1989-02-24 Cortial NEW PROCESS FOR OBTAINING EXTENDED RELEASE PHARMACEUTICAL FORMS
DE3719764A1 (en) * 1987-06-13 1988-12-22 Bayer Ag ION EXCHANGE RESINS LOADED WITH CHINOLON CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
DE69410995T2 (en) * 1993-02-17 1998-11-05 British Tech Group 1 GUANIDINO GROUPS OF POLYMERS FOR USE IN THERAPY
GB9503061D0 (en) * 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
RU2209087C2 (en) 1997-11-10 2003-07-27 Хисамицу Фармасьютикал Ко., Инк. Agent for prolonged effect of medicinal preparation and medicinal composition based on thereof
EP1745039A4 (en) * 2004-05-08 2009-07-22 Neurogen Corp 3-aryl-5,6-disubstituted pyridazines

Also Published As

Publication number Publication date
GB857193A (en) 1960-12-29

Similar Documents

Publication Publication Date Title
MY6300044A (en) Resin drug compounds
USD184888S (en) Dish
CA535449A (en) Synthetic anti-malarials
CA537126A (en) Injection moulding apparatus
CA535998A (en) Medicament base
CA535723A (en) Injection apparatus
AU218833B2 (en) PARA-a-CUMYLPHENOL-PARA-SUBSTITUTED-PHENOLFORMALDEHYDE RESIN
AU228528B2 (en) Processtor solidifyig resins
CA540457A (en) Epichlorohydrin-sulfonamide resins
IE21844L (en) Pharmaceutical composition
AU2958557A (en) PARA-a-CUMYLPHENOL-PARA-SUBSTITUTED-PHENOLFORMALDEHYDE RESIN
CA20940S (en) Dispenser
CA543994A (en) Diamine compounds
CA21391S (en) Constructional unit
CA21392S (en) Constructional unit
IE23561L (en) Aeriels
IE22780L (en) Heel-or sole-taps
AU221886B2 (en) 19-nor-androstane compounds
CA537540A (en) Organic-silicon compounds
CA539252A (en) Thiocarbhydrazine compounds
CA536582A (en) 11-oxy-spirostan compounds
AU222883B2 (en) Fulveno-metallic compounds
CA547805A (en) Benzothiazoleazoaniline compounds
CA548129A (en) 2-aminomethyl-indane compounds
CA545387A (en) Polyhalogenoalkenyl compounds